Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-05-23
2006-05-23
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S033000, C536S004100, C536S018100
Reexamination Certificate
active
07049301
ABSTRACT:
This invention relates to quercetin derivative, its preparation, and a pharmaceutical combination, as well as their medical uses for the prevention or treatment of diseases related to 5HT1Areceptor or neuron cell damages, including Alzeheimer's disease, drug or alcohol dependence, sleep disorders or panic state; and for delaying senility, improving learning and memory, preventing and treatment of neuron cell damages caused by various kinds of cerebral damages.
REFERENCES:
patent: 1232675 (1999-10-01), None
patent: 1288896 (2001-03-01), None
Yun-Feng, Li et al. “Antidepressant effect of quercetin 3-O-apiosyl (1→2)—[rhamnosyl (→6)]-glucoside in mice.” Chinese Journal of Pharmacology and Toxicology, 14(2) (2000) pp. 125-127.
Li Yunfeng
Luan Xinhui
Luo Zhipu
Yang Ming
Zhao Yimin
Academy of Military Medical Sciences Institute of Pharmacology a
Ladas and Parry LLP
Peselev Elli
LandOfFree
Quercetin derivatives and their medical usages does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quercetin derivatives and their medical usages, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quercetin derivatives and their medical usages will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530309